| Gene symbol | TNFRSF8 | Synonyms | CD30, D1S166E, Ki-1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.22 | dbXrefs | |
| Description | TNF receptor superfamily member 8 | ||||
| GTO ID | GTC2215 |
| Trial ID | NCT04134325 |
| Disease | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma |
| Altered gene | CD30 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD30 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma |
| Year | 2019 |
| Country | United States |
| Company sponsor | UNC Lineberger Comprehensive Cancer Center |
| Other ID(s) | LCCC1852-ATL |
| Cohort 1 | |||||||
|
|||||||